Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 7 Changes of patient symptom status from Day 7 to Day 37 categorized by status of significant bacteriuria

From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)

  Day 7 Day 37
N % N %
Total (N = 125a) Clinical cure 89 73.0 107 88.4
Improvement 24 19.7 10 8.2
Clinical failure 9 7.3 4 3.3
< 103/ml (N = 50) Clinical cure 44 88.0b 49 98.0b
Improvement 5 10.0 1 2.0
Clinical failure 1 2.0 0 0.0
≥ 103/ml (N = 62) Clinical cure 39 62.9b 48 77.4b
Improvement 16 25.8 9 14.5
Clinical failure 7 11.3 4 6.5
Unknown (N = 10) Clinical cure 6 60.0 10 100.0
Improvement 3 30.0 0 0.0
Clinical failure 1 10.0 0 0.0
  1. Number (N) and percentage (%) of patients whose symptom status was assessed as “Clinical cure”, “Improvement” or “Clinical failure” on Day 7 and Day 37, for all patients and categorized into subgroups with (≥ 103 colony forming units (CFU)/ml) or without (< 103 CFU/ml) significant bacteriuria (full analysis set, N = 125)
  2. alost for follow up: 3 patients on Day 7 and 4 patients on Day 37
  3. bdifference between patients with and without significant bacteriuria is statistically significant (chi2 test; p < 0.005) on Day 7 and on Day 37